Increased frequency of obstructive sleep apnea in the patients with systemic sclerosis

Gundogdu, Şule; Börekçi, Şermin; Atahan, Ersan; Müsellim, Benan

doi:10.1007/s11325-020-02080-7

Cited by 9 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In pSS, neck circumference has not been investigated previously. Regarding rheumatologic diseases, Gundogdu et al found no relationship between neck circumference and the presence of OSA in patients with systemic sclerosis [ 20 ]. In our study, the increase in neck circumference was not associated with OSA risk in pSS.…”

Section: Discussionmentioning

confidence: 99%

The frequency of obstructive sleep apnea in patients with primary Sjogren’s syndrome

et al. 2021

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The frequency of obstructive sleep apnea in patients with primary Sjogren’s syndrome

et al. 2021

Self Cite

View full text Add to dashboard Cite

“…These patients with significant ILD belong to WSPH Group 3 (PH diseases due to lung diseases and/or hypoxia). The presence of comorbid obstructive sleep apnea among patients with SSc ranges up to 50% and must be evaluated as this can contribute to changes seen in diagnostic modalities (46)(47)(48)(49). There are also increased rates of thromboembolism which can lead to the development of chronic thromboembolic pulmonary hypertension (Group 4).…”

Section: The Importance Of Phenotyping Pulmonary Hypertension In Scle...mentioning

confidence: 99%

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis

Tuhy,

Hassoun

2023

Front. Med.

View full text Add to dashboard Cite

Systemic sclerosis is an autoimmune disorder of the connective tissue characterized by disordered inflammation and fibrosis leading to skin thickening and visceral organ complications. Pulmonary involvement, in the form of pulmonary arterial hypertension and/or interstitial lung disease, is the leading cause of morbidity and mortality among individuals with scleroderma. There are no disease-specific therapies for pulmonary involvement of scleroderma, and pulmonary arterial hypertension in this cohort has typically been associated with worse outcomes and less clinical response to modern therapy compared to other forms of Group I pulmonary hypertension in the classification from the World Symposium on Pulmonary Hypertension. Ongoing research aims to delineate how pathologic microvascular remodeling and fibrosis contribute to this poor response and offer a window into future therapeutic targets.

show abstract

“…The golden standard of OSA diagnosis is polysomnography (PSG) and the golden standard treatment is the application of continuous positive airway pressure (CPAP) [ 3 , 4 ]. Many papers are reporting the significantly increased prevalence of OSA in the group of patients suffering from fibrotic diseases, including systematic sclerosis, liver fibrosis, and idiopathic pulmonary fibrosis (IPF) [ 5 , 6 , 7 ]. Fibrosis is defined as the accumulation of excess extracellular matrix components.…”

Section: Introductionmentioning

confidence: 99%

The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

Karuga

Kaczmarski

Szmyd

et al. 2022

JCM

View full text Add to dashboard Cite

The prevalence of obstructive sleep apnea (OSA) has greatly increased in recent years. Recent data suggest that severe and moderate forms of OSA affect between 6 and 17% of adults in the general population. Many papers are reporting the significantly increased prevalence of OSA in patients suffering from fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Therefore, we performed a systematic review and meta-analysis regarding the dependency between IPF and OSA. Due to the lack of papers focusing on IPF among OSA patients, we focused on the prevalence of OSA among IPF patients. In the search strategy, a total of 684 abstracts were identified, 496 after the removal of duplicates. After the screening of titles and abstracts, 31 studies were qualified for further full-text analysis for eligibility criteria. The final analysis was performed on 614 IPF patients from 18 studies, which met inclusion criteria. There were 469 (76.38%) IPF patients with OSA and 145 (23.62%) without. The mean age varied from 60.9 ± 8.1 up to 70.3 ± 7.9. The obtained prevalence was 76.4 (95% CI: 72.9–79.7) and 75.7 (95% CI: 70.1–80.9) for fixed and random effects, respectively. The median prevalence of OSA among non-IPF patients for all the ethnics groups included in this study was 16,4% (IQR: 3.4%–26.8%). The study provides strong evidence for the increased prevalence of OSA in IPF patients when comparing with the general OSA prevalence.

show abstract

Increased frequency of obstructive sleep apnea in the patients with systemic sclerosis

Cited by 9 publications

References 14 publications

The frequency of obstructive sleep apnea in patients with primary Sjogren’s syndrome

The frequency of obstructive sleep apnea in patients with primary Sjogren’s syndrome

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis

The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About